Antibacterial Agents and Release of Periplasmic Pertussis Toxin from Bordetella pertussis

AUTOR(ES)

Craig-Mylius, Kathleen A.

FONTE

American Society for Microbiology

RESUMO

Pertussis toxin accumulates in the periplasm of Bordetella pertussis prior to secretion, and we examined its fate following treatment with antimicrobial agents. Both antibiotics that inhibit protein synthesis (erythromycin and chloramphenicol), transcription (rifampin), or cell wall biosynthesis (cefoperazone and piperacillin) and magnesium sulfate (which inhibits transcription of pertussis toxin, but not bacterial growth) did not prevent release of preformed toxin. In contrast, agents that affect bacterial membranes, such as polymyxin B, lidocaine, procaine, and ethanol, inhibited release of preformed pertussis toxin. These results suggest new protein synthesis is not required for pertussis toxin secretion, but a functional membrane complex is required.

Documentos Relacionados

• CHEMICAL STUDIES ON CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS III. : Isolation of Highly Potent Toxin from Bordetella Pertussis
• Importance of Holotoxin Assembly in Ptl-Mediated Secretion of Pertussis Toxin from Bordetella pertussis
• Construction and characterization of Bordetella pertussis toxin mutants.
• Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction.
• Translocation-Specific Conformation of Adenylate Cyclase Toxin from Bordetella pertussis Inhibits Toxin-Mediated Hemolysis